Research Progress on SlitRobo Pathway in Pancreatic Cancer: Emerging and Promising

Abstract EN

Pancreatic cancer is a highly malignant digestive system tumor which is the leading cause of cancer-related deaths.

The basic and clinical research of pancreatic cancer has made great progress in recent years, and kinds of signaling pathways have been found in the tumorigenesis and progression in pancreatic cancer.

The Slit glycoprotein (Slit) and Roundabout receptor (Robo) signaling pathway acts as a neural targeting factor with the axonal remnant, axon guidance, and inhibition of neuronal migration in the nervous system.

In recent years, it has been found that the Slit/Robo signaling pathway has different degrees of expression changes in various tumor cells.

In different tumor cells, the signaling pathway gene expression is different and regulates tumor angiogenesis, cell invasion, metastasis, and nerve infiltration.

Herein, we summarize the mechanisms of the Slit/Robo pathway in the development and progression of pancreatic cancer, in order to have more understanding of the role of Slit/Robo in pancreatic cancer.